Literature DB >> 32273640

Repair of temporal branch of the facial nerve with novel polyglycolic acid-collagen tube: a case report of two cases.

Yutaka Nakamura1, Keisuke Takanari1, Katsumi Ebisawa1, Miki Kanbe1, Ryota Nakamura1, Yuzuru Kamei1.   

Abstract

Autologous nerve transplantation has been the gold standard in the treatment of facial nerve injury, however it has not been achieved satisfactory result and needs donor sacrifice. A polyglycolic acid collagen conduit (Nerbridge, Toyobo Co., Japan) has the potential to compare to or exceed autologous nerve grafts in promoting nerve regeneration. Here we report two cases of traumatic temporal facial nerve injury repairs with Nerbridge. The severed temporal branch of the facial nerve was repaired with Nerbridge conduits in two patients. Recovery of movement was assessed by clinical photography and needle electromyography. The frontal muscle started moving five months postoperatively in both cases. Electromyography at twelve months showed polymorphic electric discharge, suggesting connection of the injured nerve to the frontal muscle. In the final results, each patient had good eyebrow elevation distance and moderate forward gaze recovery in comparison to their healthy sides. Considering that facial nerves are reported to recover incompletely even in autologous nerve graft repair cases, our two cases showed reasonable recovery comparable to nerve autografting. The Nerbridge conduit is a promising alternative to standard treatments for facial nerve recovery.

Entities:  

Keywords:  artificial nerve; facial nerve injury; nerve defect; nerve regeneration; polyglycolic acid-collagen conduit

Mesh:

Substances:

Year:  2020        PMID: 32273640      PMCID: PMC7103875          DOI: 10.18999/nagjms.82.1.123

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


INTRODUCTION

Facial paralysis is not a life-threatening disease, but the associated functional, cosmetic, psychological, and social disorders are significant problems. Ideal treatment outcomes are recovery of muscle tone and symmetry at rest as well as voluntary facial movement without synkinesis. Subsequent to interruption of the facial nerve, the best functional nerve recovery reported to date is House-Brackmann (HB) Grade III (Table 1).[1-5] Autologous nerve grafting is considered to be the best choice for repair of nerve gaps, however numbness and scarring at the donor site are disadvantages. In order to overcome these drawbacks of autografts, researchers have investigated various artificial materials for nerve gap repair.
Table 1

Outcome of facial nerve reconstruction with autologous nerve graft.

studyyearCase countDuration of facial palsy (mean) (month)Meaningful outcome of postoperative facial function (≦ HB grade III) (%)
Arriaga and Brackmann.[1]199283–13 ( 7.4)13
Samii and Matthies.[2]1997421–95 (18.3)73
Falcioni et al.[3]2003561–120 (20.2)46
Gunther et al.[4]2010210.5–29 ( 5.4)86
Ozmen et al.[5]20111551–600 (25.4)68
Outcome of facial nerve reconstruction with autologous nerve graft. To date, 11 conduits are commercially available in the world. Nerbridge (Toyobo Co., Japan), the first artificial nerve designed with a two-layer structure, was approved for use in Japan in 2013 and subsequently approved by the U.S. Food and Drug Administration in 2016.[6,7] It is composed of an inner collagen spongiform matrix and surrounding outer polyglycolic acid (PGA) fiber mesh conduit providing a favorable micro-environment for nerve regeneration.[8] The regenerating nerve, guided by the surrounding outer PGA fiber mesh layer, proceeds by displacing the inner collagen bar. All synthetic components biodegrade over time. There are several clinical reports that used this new conduit for repair of peripheral sensory nerves, however its use for motor nerves has rarely been reported to date. Here we describe two cases of traumatic temporal facial nerve injuries repaired with Nerbridge.

CASE 1

A 62-year-old female slipped and fell down, injuring her right temporal region. Frontal muscle paralysis with blepharoptosis was observed after the injury and showed no subsequent improvement (Figure 1-A). One month after injury, an operative exploration was performed under general anesthesia. The temporal branch of the facial nerve was identified and a 16 mm nerve gap was observed. The proximal stump diameter was 1.0 mm and the distal stump was 0.5 mm (Figure 1-B). It was not possible to sew them directly so a 20 mm length of Nerbridge (Ø 2.5 mm) was used to interpose this gap. No notable complication was observed postoperatively. Recovery of frontal muscle movement was observed from 5 months after surgery. Although her forehead skin wrinkles and the gap of eyebrow height were not restored to their original state (HB III) (Figure 1-A), the patient was satisfied with the result. Assessment by postoperative photography revealed recovered frontal muscle movement by five months after surgery and that the final elevation distance was comparable to the healthy side (Figure 1-C). The margin reflex distance (MRD) of the injured side recovered almost completely by 10 months after operation. Electromyography at 12 months after surgery showed polymorphic electric discharge, suggesting connection of the injured frontal branch of the facial nerve to the muscle (Figure 1-D).
Fig. 1

Preoperative and postoperative findings

Frontal muscle paralysis with blepharoptosis was observed after injury and showed no improvement. Recovery of frontal muscle movement was observed from 5 months after surgery, although forehead skin wrinkles and the gap of eyebrow height did not recover to their original state (HB III). Forward gaze (above). Eyebrow elevation (below) (A). Intraoperative findings. Nerve gap was 16 mm. Distal stump diameter was 0.5 mm and proximal was 1.0 mm (arrow) (left). Nerve defect was bridged with 20 mm Nerbridge (Ø 2.5 mm) (right) (B). Analysis of postoperative photography. Red line indicates distance of eyebrow elevation and blue line indicates margin reflex distance (MRD) (above). Recovery of frontal muscle movement was observed from 5 months after repair and final elevation distance was comparable to the healthy side (below left). MRD of the affected side recovered almost completely at 10 months after operation. (below right) (C). Electromyogram twelve months after operation showed polymorphic electric discharge (arrow) (D).

Preoperative and postoperative findings Frontal muscle paralysis with blepharoptosis was observed after injury and showed no improvement. Recovery of frontal muscle movement was observed from 5 months after surgery, although forehead skin wrinkles and the gap of eyebrow height did not recover to their original state (HB III). Forward gaze (above). Eyebrow elevation (below) (A). Intraoperative findings. Nerve gap was 16 mm. Distal stump diameter was 0.5 mm and proximal was 1.0 mm (arrow) (left). Nerve defect was bridged with 20 mm Nerbridge (Ø 2.5 mm) (right) (B). Analysis of postoperative photography. Red line indicates distance of eyebrow elevation and blue line indicates margin reflex distance (MRD) (above). Recovery of frontal muscle movement was observed from 5 months after repair and final elevation distance was comparable to the healthy side (below left). MRD of the affected side recovered almost completely at 10 months after operation. (below right) (C). Electromyogram twelve months after operation showed polymorphic electric discharge (arrow) (D).

CASE 2

A 69-year-old male presented with an injury history similar to the first case. Frontal muscle paralysis with blepharoptosis was observed after injury and showed no subsequent improvement. Senile blepharoptosis contributed to his overall severe blepharoptosis (Figure 2-A). One month after injury, an operative exploration was performed under general anesthesia. The temporal branch of the facial nerve was identified with a 20 mm nerve gap. The proximal stump diameter was 1.0 mm and the distal stump was 0.5 mm (Figure 2-B). Similar to the first case, 25 mm Nerbridge (Ø 2.0 mm) was used to interpose this gap. No postoperative complication occurred and recovery of the frontal muscle movement was observed from five months after surgery. The eyebrow height gap did not recover completely (HB III), however, the final elevation distance was comparable to the healthy side (Figure 2-C). MRD improvement was unclear, possibly due to senile blepharoptosis concealing frontalis muscle movement. Electromyography 12 months postoperatively showed electric discharge equivalent to the healthy side, suggesting that improvement of the injured nerve was comparable (Figure 2-D).
Fig. 2

Preoperative and postoperative findings

The patient was not able to open the affected side of his eyelid due in part to senile blepharoptosis. Recovery of frontal muscle movement was observed from 5 months after repair. The gap of eyebrow height was not improved (A). Intraoperative findings. Nerve gap was 20 mm. Distal stump diameter was 0.5 mm and proximal was 1.0 mm (arrow) (left). Nerve defect was bridged with 25 mm Nerbridge (Ø 2.0 mm) (right) (B). Analysis of postoperative photography. Recovery of frontal muscle movement was observed from 5 months after repair and final elevation distance was comparable to the healthy side (left). MRD improvement was not clear (right) (C). Electromyogram twelve months postoperatively showed discharge comparable to the healthy side (D).

Preoperative and postoperative findings The patient was not able to open the affected side of his eyelid due in part to senile blepharoptosis. Recovery of frontal muscle movement was observed from 5 months after repair. The gap of eyebrow height was not improved (A). Intraoperative findings. Nerve gap was 20 mm. Distal stump diameter was 0.5 mm and proximal was 1.0 mm (arrow) (left). Nerve defect was bridged with 25 mm Nerbridge (Ø 2.0 mm) (right) (B). Analysis of postoperative photography. Recovery of frontal muscle movement was observed from 5 months after repair and final elevation distance was comparable to the healthy side (left). MRD improvement was not clear (right) (C). Electromyogram twelve months postoperatively showed discharge comparable to the healthy side (D).

DISCUSSION

To date, there is no established method for reanimating a paralyzed frontalis muscle by regenerating the severed frontal branch of the facial nerve. A variety of surgical approaches have been performed such as excision of the skin above the ptotic eyebrow or eyebrow lift with fascia transfer.[9] Facial nerve repair with nerve guide conduits is inadequately reported in clinical and animal studies.[10-16] In clinical cases, some conventional hollow tubes have been applied to facial nerve repair but they have not compared to autologous nerve grafts. Only Neurotube (Synovis Micro Companies Alliance, USA) has a reported clinical outcome of muscle movement recovery, but recovery of more than 60% was attained in only 1/7 of cases (14.2%).[17] In contrast, although it was a preclinical study, Inada et al reported favorable results using a 2-layer polyglycolic acid-collagen conduit.[10] This suggests that the inner collagen filling could facilitate axonal growth via a more suitable condition while inhibiting scar formation between nerve gaps and promoting effective nerve regeneration. Our study using Nerbridge showed good eyebrow elevation and moderate forward gaze improvement. A histological examination was not performed in this study, however successful motor function was revealed by photographic and electrophysiological assessment. This suggests that Nerbridge improved the movement of frontal muscles, even though some muscular atrophy occurred. In both cases, patients were satisfied with the result and did not need further revision. There is still a possibility that other near branches contributed to recovery, which is sometimes seen clinically. The duration of the preoperative facial nerve palsy is reported to be the only significant factor related to outcome.[5] In the two present cases, however, there was no sign of spontaneous recovery at one month after injury. The timing of nerve reconstruction may be clinically important. Conley[18] and May et al[19] suggested that the ideal time was within one month after injury as the results reconstructed at 4 to 6 months have been unsatisfying. Therefore, we selected to perform surgical explorations one month after the injuries. A nerve gap was identified at the injury site in each case. We believe early surgical evaluation of facial nerves is worthwhile in patients who have sustained traumatic damage to their facial skin. Additional similar studies will provide better understanding.

CONCLUSION

Considering that facial nerves are reported to recover incompletely even with autologous nerve repair, our two cases showed reasonable recovery comparable to nerve autografting. This suggests that Nerbridge is a promising alternative for the repair of motor nerve defects.

ETHICS STATEMENT

This study was received Nagoya University Hospital Institutional Review Board approval.

PATIENT CONSENT

Written informed consent was obtained from patients for publication of this case report.

ACKNOWLEDGMENTS

I would like to thank James Curley for the English language review and useful discussions.

CONFLICT OF INTEREST STATEMENT

The authors have no conflicts of interest, whether they are financial or related to any other relationships, to disclose.
  19 in total

1.  Facial nerve repair techniques in cerebellopontine angle tumor surgery.

Authors:  M A Arriaga; D E Brackmann
Journal:  Am J Otol       Date:  1992-07

2.  Facial nerve grafting.

Authors:  J J CONLEY
Journal:  Arch Otolaryngol       Date:  1961-03

3.  Managing segmental facial nerve injuries by surgical repair.

Authors:  M May; S M Sobol; S J Mester
Journal:  Laryngoscope       Date:  1990-10       Impact factor: 3.325

4.  Surgical treatment of patients with facial neuromas--a report of 26 consecutive operations.

Authors:  Mattias Günther; Niklas Danckwardt-Lillieström; Olafur Gudjonsson; Gunnar Nyberg; Anders Kinnefors; Helge Rask-Andersen; Lars Ekvall
Journal:  Otol Neurotol       Date:  2010-12       Impact factor: 2.311

5.  US Food and Drug Administration/Conformit Europe-approved absorbable nerve conduits for clinical repair of peripheral and cranial nerves.

Authors:  M F Meek; J H Coert
Journal:  Ann Plast Surg       Date:  2008-01       Impact factor: 1.539

6.  An alternative to the classical nerve graft for the management of the short nerve gap.

Authors:  A L Dellon; S E Mackinnon
Journal:  Plast Reconstr Surg       Date:  1988-11       Impact factor: 4.730

7.  Collagen scaffolds modified with CNTF and bFGF promote facial nerve regeneration in minipigs.

Authors:  Yi Cui; Chao Lu; Danqing Meng; Zhifeng Xiao; Xianglin Hou; Wenyong Ding; Depeng Kou; Yao Yao; Bing Chen; Zhen Zhang; Jiayin Li; Juli Pan; Jianwu Dai
Journal:  Biomaterials       Date:  2014-06-13       Impact factor: 12.479

8.  A modified frontalis sling in the treatment of combined blepharoptosis and facial nerve paresis.

Authors:  L A Chait; M S Fayman
Journal:  Br J Plast Surg       Date:  1989-09

9.  Application of neural stem cells in tissue-engineered artificial nerve.

Authors:  Bao-Feng Guo; Ming-Min Dong
Journal:  Otolaryngol Head Neck Surg       Date:  2009-02       Impact factor: 3.497

10.  Chitosan conduits combined with nerve growth factor microspheres repair facial nerve defects.

Authors:  Huawei Liu; Weisheng Wen; Min Hu; Wenting Bi; Lijie Chen; Sanxia Liu; Peng Chen; Xinying Tan
Journal:  Neural Regen Res       Date:  2013-11-25       Impact factor: 5.135

View more
  2 in total

Review 1.  Facial Nerve Repair: Bioengineering Approaches in Preclinical Models.

Authors:  Fuat Baris Bengur; Conrad Stoy; Mary A Binko; Wayne Vincent Nerone; Caroline Nadia Fedor; Mario G Solari; Kacey G Marra
Journal:  Tissue Eng Part B Rev       Date:  2021-04-13       Impact factor: 7.376

2.  Intraoperative obturator nerve injury reconstructed using a PGA-collagen tube: Three case reports.

Authors:  Atsuhiko Iwao; Maoko Yagi; Yoshinobu Imamura; Akihito Higashi; Yuki Moriuchi; Kazuya Kashiyama; Katsumi Tanaka
Journal:  Gynecol Oncol Rep       Date:  2022-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.